insights_auto
Why is CUV down 2,88%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7,42
arrow_downward
-2,88%(-0,22) 1D
13 Nov., 16:10:12 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7,55
High
A$7,57
Low
A$7,34
Mkt. cap
374,61 m
Avg. vol.
157,39 k
Volume
0,00
Dividend
0,67%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,11
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
Open
A$7,55
High
A$7,57
Low
A$7,34
Mkt. cap
374,61 m
Avg. vol.
157,39 k
Volume
0,00
Dividend
0,67%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,11
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
News stories
From web sources and news partners
Benzinga
·
27 minute gelede
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
BigGo Finance
·
7 uur gelede
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
2 uur gelede
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Traders Union
·
5 uur gelede
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
Industry-
Websiteclinuvel.com